These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15505087)

  • 1. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century.
    Pinti M; Troiano L; Nasi M; Bellodi C; Ferraresi R; Mussi C; Salvioli G; Cossarizza A
    Circulation; 2004 Nov; 110(19):3108-14. PubMed ID: 15505087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
    Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
    Kaser A; Nagata S; Tilg H
    Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human colon cancer cells express the functional Fas ligand.
    Ding EX; Hizuta A; Morimoto Y; Tanida T; Hongo T; Ishii T; Yamano T; Fujiwara T; Iwagaki H; Tanaka N
    Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):13-24. PubMed ID: 9755840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
    Ragnarsson GB; Mikaelsdottir EK; Vidarsson H; Jónasson JG; Olafsdóttir K; Kristjánsdóttir K; Kjartansson J; Ogmundsdóttir HM; Rafnar T
    Br J Cancer; 2000 Dec; 83(12):1715-21. PubMed ID: 11104571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
    Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Fas, FasL, and soluble Fas mRNA in endomyocardial biopsies of human cardiac allografts.
    Pérez EC; Shulzhenko N; Morgun A; Diniz RV; Almeida DR; Musatti CC; Gerbase-DeLima M
    Hum Immunol; 2006; 67(1-2):22-6. PubMed ID: 16698421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of apoptotic markers Fas/FasL (CD95/CD95L) expression on the lymphocytes in patients with acute coronary syndrome.
    Bossowska A; Bossowski A; Galar B
    Kardiol Pol; 2007 Aug; 65(8):883-9; discussion 890-2. PubMed ID: 17853317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
    Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
    Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis.
    Bühling F; Wille A; Röcken C; Wiesner O; Baier A; Meinecke I; Welte T; Pap T
    Respir Res; 2005 Apr; 6(1):37. PubMed ID: 15833141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis of peripheral blood mononuclear cells in Kawasaki disease.
    Kim HY; Lee HG; Kim DS
    J Rheumatol; 2000 Mar; 27(3):801-6. PubMed ID: 10743828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cigarette smoking on Fas/Fas ligand expression of human lymphocytes.
    Suzuki N; Wakisaka S; Takeba Y; Mihara S; Sakane T
    Cell Immunol; 1999 Feb; 192(1):48-53. PubMed ID: 10066346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
    Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
    Int J Oncol; 2001 Jan; 18(1):33-9. PubMed ID: 11115536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased oxidant-induced apoptosis in cultured nondividing human retinal pigment epithelial cells.
    Jiang S; Moriarty SE; Grossniklaus H; Nelson KC; Jones DP; Sternberg P
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2546-53. PubMed ID: 12147583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
    Bellone G; Smirne C; Carbone A; Mareschi K; Dughera L; Farina EC; Alabiso O; Valente G; Emanuelli G; Rodeck U
    Clin Cancer Res; 2000 Jun; 6(6):2448-55. PubMed ID: 10873098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
    Ogawa S; Nagao M; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Nakajima Y
    Anticancer Res; 2004; 24(3a):1569-79. PubMed ID: 15274324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.